Research graph
References from Annual trends in Mycobacterium tuberculosis detection and rifampicin resistance at a regional referral hospital in Northern Ghana, 2019–2024. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2024 · External reference
The global tuberculosis epidemic and progress in care, prevention, and research
10.1016/s2213-2600(18)30057-2 · 2019 · External reference
Tuberculosis
10.1038/nrdp.2016.76 · 2016 · External reference
Unresolved reference
2022 · External reference
Global tuberculosis report 2020—reflections on the global TB burden, treatment and prevention efforts
10.1016/j.ijid.2021.02.107 · 2021 · External reference
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
2017 · External reference
Rapid molecular detection of tuberculosis and rifampin resistance
10.1056/nejmoa0907847 · 2010 · External reference
Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe
10.1371/journal.pone.0193577 · 2018 · External reference
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
10.1002/14651858.cd009593.pub2 · 2013 · External reference
Geographical Accessibility to District Hospitals/Medical Laboratories for Comprehensive Antenatal Point-of-Care Diagnostic Services in the Upper East Region, Ghana
10.1016/j.eclinm.2019.06.015 · 2019 · External reference
Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
10.1371/journal.pone.0198695 · 2018 · External reference
Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens
10.4103/ijmy.ijmy_83_19 · 2019 · External reference
Drug resistance in Ghana
2011 · External reference
Unresolved reference
2022 · External reference
The burden of drug resistance tuberculosis in Ghana; results of the First National Survey
10.1371/journal.pone.0252819 · 2021 · External reference
Trends of Mycobacterium tuberculosis and rifampicin resistance at the Ho Teaching Hospital in Ghana
2024 · External reference
Trends in TB case detection in Ghana
2016 · External reference
Rapid Diagnosis of Drug-Resistant Tuberculosis-Opportunities and Challenges
10.3390/pathogens13010027 · 2023 · External reference
The population dynamics of tuberculosis
10.1126/science.1185449 · 2010 · External reference
The impact of COVID-19 on TB: a review of the data
10.5588/ijtld.21.0148 · 2021 · External reference
Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns
10.1164/rccm.200503-449oc · 2005 · External reference
Tuberculosis 2015: burden, challenges and strategy
2016 · External reference
Tuberculosis control in Africa
2011 · External reference
The evolving biology of Mycobacterium tuberculosis drug resistance
10.3389/fcimb.2022.1027394 · 2022 · External reference
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
10.1002/14651858.cd009593.pub2 · ExternalCitation · doi-reference
Geographical Accessibility to District Hospitals/Medical Laboratories for Comprehensive Antenatal Point-of-Care Diagnostic Services in the Upper East Region, Ghana
10.1016/j.eclinm.2019.06.015 · ExternalCitation · doi-reference
Global tuberculosis report 2020—reflections on the global TB burden, treatment and prevention efforts
10.1016/j.ijid.2021.02.107 · ExternalCitation · doi-reference
The global tuberculosis epidemic and progress in care, prevention, and research
10.1016/s2213-2600(18)30057-2 · ExternalCitation · doi-reference
Tuberculosis
10.1038/nrdp.2016.76 · ExternalCitation · doi-reference
Rapid molecular detection of tuberculosis and rifampin resistance
10.1056/nejmoa0907847 · ExternalCitation · doi-reference
The population dynamics of tuberculosis
10.1126/science.1185449 · ExternalCitation · doi-reference
Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns
10.1164/rccm.200503-449oc · ExternalCitation · doi-reference
Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe
10.1371/journal.pone.0193577 · ExternalCitation · doi-reference
Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
10.1371/journal.pone.0198695 · ExternalCitation · doi-reference
The burden of drug resistance tuberculosis in Ghana; results of the First National Survey
10.1371/journal.pone.0252819 · ExternalCitation · doi-reference
The evolving biology of Mycobacterium tuberculosis drug resistance
10.3389/fcimb.2022.1027394 · ExternalCitation · doi-reference
Rapid Diagnosis of Drug-Resistant Tuberculosis-Opportunities and Challenges
10.3390/pathogens13010027 · ExternalCitation · doi-reference
Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens
10.4103/ijmy.ijmy_83_19 · ExternalCitation · doi-reference
The impact of COVID-19 on TB: a review of the data
10.5588/ijtld.21.0148 · ExternalCitation · doi-reference
